Molecular cytometry of cancer

Human Pathology

Volumn 27, Issue 5, 1996, Pages 441-449

  Waldman, Frederic M ^a   Sauter, G ^b   Sudar, D ^b   Thompson, C T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

cancer; comparative genomic hybridization; cytogenetics; cytometry; fluorescent in situ hybridization

Indexed keywords

DNA;

BREAST CANCER; CANCER CYTODIAGNOSIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENOME; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN SITU HYBRIDIZATION; LEUKEMIA; MOLECULAR GENETICS; SOLID TUMOR;

EID: 0030005702     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90088-X     Document Type: Conference Paper

References (72)

1. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532, 1988
2. Rodriguez E, Sreekantaiah C, Chaganti RSK; Genetic changes in epithelial solid neoplasia. Cancer Res 54:3398-3406, 1994
3. Gray JW, Kallioniemi A, Kallioniemi O, et al: Molecular cytogenetics: Diagnosis and prognostic assessment. Curr Opin in Biotechnol 3:623-631, 1992
4. Waldman F, Sauter G, Isola J, et al: Molecular cytogenetics of solid tumor progression, in Li J (ed): Hormonal Carcinogenesis. New York, Springer-Verlag, 1996, pp 68-78
5. Alcaraz A, Takahashi S, Brown JA, et al: Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002, 1994
6. Bandyk MG, Zhao L, Troncoso P, et al: Trisomy 7: A potential cytogenetic marker of human prostate cancer progression. Genes Chromosom Cancer 9:19-27, 1994
7. Chen Z, Morgan R, Stone JF, et al: FISH: A useful technique in the verification of clonality of random chromosome abnormalities. Cancer Genet Cytogenet 66:73-74, 1993
8. Chen Z, Morgan R, Stone JF, et al: Identification of complex t(15, 17) in APL by FISH. Cancer Genet Cytogenet 72:73-74, 1994
9. Fugazza G, Bruzzone R, Dejana AM, et al: Trisomy 8 detection in Ph+ CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques. Cancer Genet Cytogenet 72:24-27, 1994
10. Jenkins RB, Le Beau MM, Kraker WJ, et al: Fluorescence in situ hybridization: A sensitive method for trisomy 8 detection in bone marrow specimens. Blood 79:3307-3315, 1992
11. Cajulis RS, Frias-Hidvegi D: Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes. Acta Cytol 37:391-396, 1993
12. Sauter G, Feichter G, Torhorst J, et al: Fluorescence in situ hybridization to detect ErbB-2 amplification in breast tumor fine needle aspiration biopsies. Acta Cytol (in press)
13. Kallioniemi A, Kallioniemi O, Sudar D, et al: Comparative genomic hybridization: A powerful new method for cytogenetic analysis of solid tumors. Science 258:818-821, 1992
14. Waldman F, Carroll PR, Kerschmann R, et al: Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 51:3807-3813, 1991
15. Kallioniemi O, Kallioniemi A, Kurisu W, et al: C-ErbB2 oncogene amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89:5321-5325, 1992
16. Sauter G, Deng G, Moch H, et al: Physical deletion of the p53 gene in bladder cancer: Detection by fluorescence in situ hybridization. Am J Pathol 144:756-766, 1994
17. Matsumura K, Kallioniemi O, Kallioniemi A, et al: Detection of deletions at 17p13 in human breast cancer detected by fluorescence in situ hybridization. Cancer Res 52:3474-3477, 1992
18. Nederlof PM, van der Flier S, Vrolijk J, et al: Fluorescence ratio measurements of double-labeled probes for multiple in situ hybridization by digital imaging microscopy. Cytometry 13:839-845, 1992
19. Lengauer C, Speicher MR, Popp S, et al: Chromosomal bar codes produced by multicolor fluorescence in situ hybridization with multiple YAC clones and whole chromosome painting probes. Hum Mol Genet 2:515-512, 1993
20. Speel EJ, Herbergs J, Ramaekers FC, et al: Combined immunocytochemistry and fluorescence in situ hybridization for simultaneous tricolor detection of cell cycle, genomic, and phenotypic parameters of tumor cells. J Histochem Cytochem 42:961-966, 1994
21. Sauter G, Moch H, Moore D, et al: Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res 53:1-8, 1993
22. Fidlerova H, Senger G, Kost M, et al: Two simple procedures for releasing chromatin from routinely fixed cells for fluorescence in situ hybridization. Cytogenet Cell Genet 65:203-205, 1994
23. Cajulis RS, Frias-Hidvegi D: Detection of numerical chromosomal abnormalities in malignant cells on body fluids by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes. Diagn Cytopathol 8:627-631, discussion 631, 662, 1992
24. Wheeless L, Reeder J: Exfoliated cell analysis in bladder cancer by fluorescence in situ hybridization. Cytometry 12:20-30, 1995
25. de Wit PE, Hopman AH, van Muijen GN, et al: In situ detection of supernumerary aberrations of chromosome-specific repetitive DNA targets in interphase nuclei in human melanoma cell lines and tissue sections. J Invest Dermatol 98:450-458, 1992
26. Dhingra K, Sahin A, Supak J, et al: Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: Technical considerations and biological implications. Breast Cancer Res Treat 23:201-210, 1992
27. Dhingra K, Sneige N, Pandita TK, et al: Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections. Cytometry 16:100-112, 1994
28. Hopman AH, van Hooren E, van de Kaa CA, et al: Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod Pathol 4:503-513, 1991
29. Kim SY, Lee JS, Ro JY, et al: Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization: Mapping genotype/phenotype heterogeneity. Am J Pathol 142:307-317, 1993
30. van Lijnschoten G, Albrechte J, Vallinga M, et al: Fluorescence in situ hybridization on paraffin-embedded abortion material as a means of retrospective chromosome analysis. Hum Genet 94:518-522, 1994
31. Wolman SR: Fluorescence in situ hybridization: A new tool for the pathologist. HUM PATHOL 25:586-590, 1994
32. Voravud N, Shin DM, Ro JY, et al: Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 53:2874-2883, 1993
33. Micale MA, Visscher DW, Gulino SE, et al: Chromosomal aneuploidy in proliferative breast disease. HUM PATHOL 25:29-35, 1994
34. Thompson CT, LeBoit PE, Nederlof PM, et al: Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile. Am J Pathol 144:237-243, 1994
35. Lockett S, Thompson CT, Mullikin J, et al: Interactive algorithms for rapid enumeration of hybridization signals in individual whole cell nuclei inside intact tissue specimens. Proceedings of the SPIE 1995 (in press)
36. du Manoir S, Speicher MR, Joos S, et al: Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590-610, 1993
37. Kallioniemi OP, Kallioniemi A, Piper J, et al: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10:231-243, 1994
38. du Manoir S, Kallioniemi OP, Lichter P, et al: Hardware and software requirements for quantitative analysis of comparative genomic hybridization. Cytometry 19:4-9, 1995
39. du Manoir S, Schrock E, Bentz M, et al: Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41, 1995
40. Isola J, DeVries S, Chu L, et al: Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145:1301-1308, 1994
41. Wheeless LL: The clinical utility of DNA cytometry. Ann N Y Acad Sci 677:82-85, 1993
42. Cohen C: Image cytometric analysis in pathology. HUM PATHOL 27:482-493, 1996
43. Trask B, van den Engh G, Pinkel D, et al: Fluorescence in situ hybridization to interphase cell nuclei in suspension allows flow cytometric analysis of chromosome content and microscopic analysis of nuclear organization. Hum Genet 78:251-259, 1988
44. Gray JW, Pallavicini MG: Molecular cytogenetics: Solid tumors and leukemia. Blood Cells 19:677-683, 1993
45. Beck JL, Hopman AH, Vooijs GP, et al: Chromosome detection by in situ hybridization in cancer cell populations which were flow cytometrically sorted after immunolabeling. Cytometry 13:346-355, 1992
46. Szollosi J, Lockett SJ, Balazs M, et al: Correction of autofluorescence in digital images of fluorescence in situ hybridization. Cytometry 24:356-361, 1995
47. Waks A, Ginsburg H: A multi-disciplinary approach for detecting sub-cellular objects in low level light fluorescence microscopy, in Titus HC, Waks A (eds): Image Acquisition and Scientific Imaging Systems. Proc. SPIE 2173, 1994, pp 36-44
48. Gray JW, Moore D, Piper J, et al: Molecular cytogenetic approaches to the development of biomarkers. Biomarkers for Worker Health Monitoring 100-120, 1994
49. Piper J, Poggensee M, Hill W, et al: Automatic fluorescence metaphase finder speeds translocation scoring in FISH painted chromosomes. Cytometry 16:7-16, 1994
50. Raap T: Editorial: Cytometry for CGH. Cytometry 19:1-3, 1995
51. Piper J, Rutovitz D, Sudar D, et al: Computer image analysis of comparative genomic hybridization. Cytometry 19:10-26, 1995
52. Lundsteen C, Maahr J, Christensen B, et al: Image analysis in comparative genomic hybridization. Cytometry 19:42-50, 1995
53. Rowley JD: Molecular cytogenetics: Rosetta stone for understanding cancer: Twenty-ninth G. H. A. Clowes memorial award lecture. Cancer Res 50:3816-3825, 1990
54. Sandberg AA: Chromosome abnormalities in human cancer and leukemia. Mutat Res 247:231-240, 1991
55. Heim S, Mitelman F: Cytogenetic analysis in the diagnosis of acute leukemia. Cancer 70:1701-1709, 1992 (suppl 6)
56. Chen Z, Morgan R, Berger CS, et al: Application of fluores-cence in situ hybridization in hematological disorders. Cancer Genet Cytogenet 63:62-69, 1992
57. Amiel A, Yarkoni S, Slavin S, et al: Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization. Cancer Genet Cytogenet 76:59-64, 1994
58. Zhao L, Kantarjian HM, Van Oort J, et al: Detection of residual proliferating leukemic cells by fluorescence in situ hybridization in CML patients in complete remission after interferon treatment. Leukemia 7:168-171, 1993
59. Bentz M, Dohner H, Cabot G, et al: Fluorescence in situ hybridization in leukemias: The FISH are spawningl' Leukemia 8:1447-1452, 1994
60. Anastasi J: Fluorescence in situ hybridization in leukemia: Applications in diagnosis, subclassification, and monitoring the response to therapy. Ann N Y Acad Sci 677:214-224, 1993
61. Anastasi J, Vardiman JW, Rudinsky R, et al: Direct correlation of cytogenetic findings with cell morphology using in situ hybridization: An analysis of suspicious cells in bone marrow specimens of two patients completing therapy for acute lymphoblastic leukemia. Blood 77:2456-2462, 1991
62. Nylund SJ, Ruutu T, Saarinen U, et al: Detection of minimal residual disease using fluorescence DNA in situ hybridization: A follow-up study in leukemia and lymphoma patients. Leukemia 8:587-594, 1994
63. Carothers AD: Counting, measuring, and mapping in FISH-labelled cells: Sample size considerations and implications for automation. Cytometry 16:298-304, 1994
64. Persons DL, Takai K, Gibney DJ, et al: Comparison of fluorescence in situ hybridization with flow cytometry and static image analysis in ploidy analysis of paraffin-embedded prostate adenocarcinoma. HUM PATHOL 25:678-683, 1994
65. Ramaekers FC, Hopman AH: Detection of genetic aberrations in bladder cancer using in situ hybridization. Ann N Y Acad Sci 677:199-213, 1993
66. Balazs M, Matsumura K, Moore D, et al: Karyotypic heterogeneity and its relation to labeling index in interphase breast tumor cells. Cytometry 20:62-73, 1995
67. Kallioniemi A, Kallioniemi O, Sudar D, et al: Identification of amplified regions in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160, 1994
68. Kallioniemi A, Kallioniemi O, Citro G, et al: Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosom Cancer 12:213-219, 1995
69. Schrock E, Thiel G, Lozanova T, et al: Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144:1203-1218, 1994
70. Speicher MR, Prescher G, du Manoir S, et al: Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res 54:3817-3823, 1994
71. Isola J, Kallioniemi O, Chu L, et al: Genetic aberrations detected by comparative genomic hybridization (CGH) predict outcome in node-negative breast cancer. Am J Pathol 147:905-911, 1995
72. Kallioniemi OP, Kallioniemi A, Sudar D, et al: Comparative genomic hybridization: A rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biology 4:41-46, 1993